Research

Energy balance

Significant disproportionality for semaglutide remained in patients with coreported use of antidepressants and benzodiazepines.

Clinicians should consider the interaction of semaglutide with antidepressants and benzodiazepines when assessing risk.

StrongSupportsmedium confidence
which remained significant in patients with coreported use of antidepressants (ROR, 4.45; 95% CI, 2.52-7.86; IC, 1.96; 95% CI, 0.98-2.63) and benzodiazepines (ROR, 4.07; 95% CI, 1.69-9.82; IC, 1.67; 95% CI, 0.11-2.65).
Georgios Schoretsanitis et al. · JAMA Network Open · 2024

Why this rating

Based on the analysis of WHO data.

Source

Disproportionality Analysis From World Health Organization Data on Semaglutide, Liraglutide, and Suicidality

Georgios Schoretsanitis et al. · JAMA Network Open · 2024

DOI 10.1001/jamanetworkopen.2024.23385

other · n=269Cited 86×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →